SLN
Silence TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
SLN vs peer average
15/100
SLN vs. peer average (F vs. B)
Grade spread
A 3 · B 4 · C 3 · D 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
LRMR is the first available peer comparator.
Clinical-stage small-cap biotech with a concentrated lead-asset thesis and sharp repricing around binary development milestones; useful as a risk-profile peer more than a mechanistic peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SLN
Silence Therapeutics
LRMR
Larimar Therapeutics
Grade
F
B
Momentum
96
34
Value
41
41
Sentiment
4
83
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs LRMR
SLN / LRMR
Grade Position
Below peers
SLN vs. peer average (F vs. B)
15/100
Momentum
96
SLNValue
41
SLNSentiment
4
LRMRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SLN
LRMR is the first peer returned for this comparison set.